SCHEMBL21169740

SCHEMBL21169740

Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)(C)O)n2)c(OC(C)C)cc1C1CCNCC1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 18/20 0.82
INSR P06213 10/20 0.82
KCNH2 Q12809 4/20 0.82
EGFR P00533 2/20 0.82
PLK4 O00444 1/20 0.82
BUB1B O60566 1/20 0.82
JAK2 O60674 1/20 0.82
ROCK2 O75116 1/20 0.82
ABL1 P00519 1/20 0.82
NTRK1 P04629 1/20 0.82
LCK P06239 1/20 0.82
NPM1 P06748 1/20 0.82
FES P07332 1/20 0.82
LYN P07948 1/20 0.82
RET P07949 1/20 0.82
IGF1R P08069 1/20 0.82
ABCB1 P08183 1/20 0.82
MET P08581 1/20 0.82
ROS1 P08922 1/20 0.82
FGR P09769 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21170018 0.94 ALK (0.80) ALKINSRKCNH2EGFRPLK4
SCHEMBL19870462 0.94 ALK (0.85) ALKINSRKCNH2EGFRPLK4
SCHEMBL19557697 0.93 ALK (0.82) ALKINSRKCNH2EGFRPLK4
SCHEMBL21169823 0.92 ALK (0.86) ALKINSRKCNH2EGFRPLK4
SCHEMBL21169756 0.92 ALK (0.76) ALKINSRKCNH2EGFRPLK4
SCHEMBL19557686 0.91 ALK (0.80) ALKINSRKCNH2EGFRPLK4
SCHEMBL23637757 0.91 ALK (0.87) ALKINSRKCNH2EGFRPLK4
Ceritinib SCHEMBL29349781 0.90 ALK (1.00) ALKINSRKCNH2EGFRPLK4
Ceritinib SCHEMBL1014329 0.90 ALK (1.00) ALKINSRKCNH2EGFRPLK4
Ceritinib SCHEMBL29489147 0.90 ALK (1.00) ALKINSRKCNH2EGFRPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990405-B1 DEUTERATED DIAMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUNDS SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD (CN) 2019-07-17 EP disclosed